Establishing Pathological Cut-Offs of Brain Atrophy Rates in Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp-2014-309903
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Brain Atrophy in Multiple Sclerosis: Mechanisms, Clinical Relevance and Treatment Options

Autoimmunity Highlights
RheumatologyImmunology
2019English

Association of Retinal and Macular Damage With Brain Atrophy in Multiple Sclerosis

PLoS ONE
Multidisciplinary
2011English

Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis

Frontiers in Neurology
Neurology
2019English

Estimates of Age-Dependent Cut-Offs for Pathological Brain Volume Loss Using SIENA/FSL – A Longitudinal Brain Volumetry Study in Healthy Adults

Neurobiology of Aging
AgingGerontologyDevelopmental BiologyGeriatricsNeuroscienceNeurology
2018English

Sample Sizes for Brain Atrophy Outcomes in Trials for Secondary Progressive Multiple Sclerosis

Neurology
Neurology
2008English

What Causes Deep Gray Matter Atrophy in Multiple Sclerosis?

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2018English

Frontal Cortex Atrophy Predicts Cognitive Impairment in Multiple Sclerosis

Journal of Neuropsychiatry and Clinical Neurosciences
MedicinePsychiatryMental HealthNeurology
2002English

Pathological Substrate for Regional Distribution of Increased Atrophy Rates in Progressive Supranuclear Palsy

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2004English

Hospitalization Rates and Discharge Status in Multiple Sclerosis

Multiple Sclerosis International
Neurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy